A patient on warfarin starts a new drug that inhibits CYP2C9. What is the most likely consequence?
Show answer and explanation
Correct answer: Increased warfarin levels and bleeding risk
Inhibition of CYP2C9 reduces warfarin metabolism, increasing its plasma concentration and enhancing anticoagulant effect, leading to bleeding.
Practice all 19 Adverse Drug Reactions and Interactions questions
Keep practicing
More Adverse Drug Reactions and Interactions questions
- Which mechanism underlies many serious drug–drug interactions (DDIs)?
- Grapefruit juice can increase plasma levels of certain medications by inhibiting which enzyme in the gut and liver?
- Which combination is especially dangerous due to additive risk of QT prolongation and torsades de pointes?
- Which factor increases the risk of adverse drug reactions in a patient?
- Which scenario best illustrates a pharmacodynamic drug–drug interaction?
- A patient develops neutropenia after a course of chloramphenicol. This ADR is best classified as which type?